adherence

Nonadherence costs pharma $600B-plus in annual sales: study

Pharma loses $637 billion annually, with $250 billion in the U.S. alone last year, attributed to patient nonadherence to medications, according to a new study from HealthPrize and Capgemini.

Beth Snyder Bulik Nov 22, 2016 9:16am

Game-playing patients more likely to refill meds: Study

Apr 19, 2016 4:57pm